메뉴 건너뛰기




Volumn 18, Issue 3, 2011, Pages 158-165

Hydroxyurea for sickle cell anemia: What have we learned and what questions still remain?

Author keywords

global health; hydroxyurea; mortality; sickle cell anemia

Indexed keywords

HYDROXYUREA; PENICILLIN G; PLACEBO;

EID: 79955011693     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32834521dd     Document Type: Article
Times cited : (127)

References (54)
  • 1
    • 77949441790 scopus 로고    scopus 로고
    • Developing a global agenda for sickle cell disease: Report of an international symposium and workshop in Cotonou, Republic of Benin
    • Odame I. Developing a global agenda for sickle cell disease: report of an international symposium and workshop in Cotonou, Republic of Benin. Am J Prev Med 2010; 38 (4 Suppl):S571-S575.
    • (2010) Am J Prev Med , vol.38 , Issue.4 SUPPL.
    • Odame, I.1
  • 2
    • 77949482609 scopus 로고    scopus 로고
    • Population estimates of sickle cell disease in the U.S
    • Hassell KL Population estimates of sickle cell disease in the U.S. Am J Prev Med 2010; 38 (4 Suppl):S512-S521.
    • (2010) Am J Prev Med , vol.38 , Issue.4 SUPPL.
    • Hassell, K.L.1
  • 3
    • 0001700270 scopus 로고
    • Hereditary persistence of fetal hemoglobin: A study of 79 affected persons in 15 Negro families in Baltimore
    • Conley CL, Weatherall DJ, Richardson SN, et al. Hereditary persistence of fetal hemoglobin: a study of 79 affected persons in 15 Negro families in Baltimore. Blood 1963; 21:261-281.
    • (1963) Blood , vol.21 , pp. 261-281
    • Conley, C.L.1    Weatherall, D.J.2    Richardson, S.N.3
  • 4
    • 0025653912 scopus 로고
    • Fetal hemoglobin, sickling, and sickle cell disease
    • Charache S. Fetal hemoglobin, sickling, and sickle cell disease. Adv Pediatr 1990; 37:1-31.
    • (1990) Adv Pediatr , vol.37 , pp. 1-31
    • Charache, S.1
  • 5
    • 0021286875 scopus 로고
    • Hydroxyurea enhanced fetal hemoglobin production in sickle cell anemia
    • Platt OS, Orkin SH, Dover G, et al. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest 1984; 74:652-656. (Pubitemid 14054015)
    • (1984) Journal of Clinical Investigation , vol.74 , Issue.2 , pp. 652-656
    • Platt, O.S.1    Orkin, S.H.2    Dover, G.3
  • 6
    • 0028913012 scopus 로고
    • Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis
    • Cortelazzo S, Finazzi G, Ruggeri M, et al. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. N Engl J Med 1995; 332:1132-1136.
    • (1995) N Engl J Med , vol.332 , pp. 1132-1136
    • Cortelazzo, S.1    Finazzi, G.2    Ruggeri, M.3
  • 7
  • 8
    • 0014023973 scopus 로고
    • Metabolic and therapeutic effects of hydroxyurea in chronic myeloid leukemia
    • Kennedy BJ, Yarbro JW. Metabolic and therapeutic effects of hydroxyurea in chronic myeloid leukemia. J Am Med Assoc 1966; 195:1038-1043.
    • (1966) J Am Med Assoc , vol.195 , pp. 1038-1043
    • Kennedy, B.J.1    Yarbro, J.W.2
  • 10
    • 0014409894 scopus 로고
    • Effect of hydroxyurea on ribonucleotide reductase
    • Elford HL Effect of hydroxyurea on ribonucleotide reductase. Biochem Biophys Res Commun 1968; 33:129-135.
    • (1968) Biochem Biophys Res Commun , vol.33 , pp. 129-135
    • Elford, H.L.1
  • 11
    • 0026631318 scopus 로고
    • Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia
    • Charache S, Dover GJ, Moore RD, et al. Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia. Blood 1992; 79:2555-2565.
    • (1992) Blood , vol.79 , pp. 2555-2565
    • Charache, S.1    Dover, G.J.2    Moore, R.D.3
  • 13
    • 63649117820 scopus 로고    scopus 로고
    • A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia
    • Thornburg CD, Dixon N, Burgett S, et al. A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia. Pediatr Blood Cancer 2009; 52:609-615.
    • (2009) Pediatr Blood Cancer , vol.52 , pp. 609-615
    • Thornburg, C.D.1    Dixon, N.2    Burgett, S.3
  • 14
    • 27144448031 scopus 로고    scopus 로고
    • Long-term hydroxyurea therapy for infants with sickle cell anemia: The HUSOFT extension study
    • DOI 10.1182/blood-2004-12-4973
    • Hankins JS, Ware RE, Rogers ZR, et al. Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study. Blood 2005; 106:2269-2275. (Pubitemid 41510795)
    • (2005) Blood , vol.106 , Issue.7 , pp. 2269-2275
    • Hankins, J.S.1    Ware, R.E.2    Rogers, Z.R.3    Wynn, L.W.4    Lane, P.A.5    Scott, J.P.6    Wang, W.C.7
  • 15
    • 79954999874 scopus 로고    scopus 로고
    • Hydroxyurea treatment of infants with sickle cell anemia: Results of the BABY HUG study
    • ASPHO Annual Meeting Abstract
    • Wang W, Thompson B. Hydroxyurea treatment of infants with sickle cell anemia: results of the BABY HUG study. ASPHO Annual Meeting Abstract. Pediatr Blood Cancer 2010; 54:787.
    • (2010) Pediatr Blood Cancer , vol.54 , pp. 787
    • Wang, W.1    Thompson, B.2
  • 16
    • 49349104104 scopus 로고    scopus 로고
    • A cell stress signaling model of fetal hemoglobin induction; What doesn't kill red blood cells makes them stronger
    • Mabaera R, West RJ, Conine SJ, et al. A cell stress signaling model of fetal hemoglobin induction; what doesn't kill red blood cells makes them stronger. Exp Hematol 2008; 36:1057-1072.
    • (2008) Exp Hematol , vol.36 , pp. 1057-1072
    • Mabaera, R.1    West, R.J.2    Conine, S.J.3
  • 18
    • 38949192565 scopus 로고    scopus 로고
    • Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells
    • DOI 10.1182/blood-2007-05-088732
    • Cokic VP, Andric SA, Stojilkovic SS, et al. Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells. Blood 2008; 111:111 7-1123. (Pubitemid 351213390)
    • (2008) Blood , vol.111 , Issue.3 , pp. 1117-1123
    • Cokic, V.P.1    Andric, S.A.2    Stojilkovic, S.S.3    Noguchi, C.T.4    Schechter, A.N.5
  • 20
    • 77955905049 scopus 로고    scopus 로고
    • How i use hydroxyurea to treat young patients with sickle cell anemia
    • Ware RE. How I use hydroxyurea to treat young patients with sickle cell anemia. Blood 2010; 115:5300-5311.
    • (2010) Blood , vol.115 , pp. 5300-5311
    • Ware, R.E.1
  • 21
    • 74749106742 scopus 로고    scopus 로고
    • Hydroxyurea for children with sickle cell disease
    • Heeney MM, Ware RE. Hydroxyurea for children with sickle cell disease. Hematol Oncol Clin North Am 2010; 24:199-214.
    • (2010) Hematol Oncol Clin North Am , vol.24 , pp. 199-214
    • Heeney, M.M.1    Ware, R.E.2
  • 23
    • 1542373662 scopus 로고    scopus 로고
    • Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease
    • DOI 10.1182/blood-2003-07-2475
    • Zimmerman SA, Schultz WH, Davis JS, et al. Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood 2004; 103:2039-2045. (Pubitemid 38326218)
    • (2004) Blood , vol.103 , Issue.6 , pp. 2039-2045
    • Zimmerman, S.A.1    Schultz, W.H.2    Davis, J.S.3    Pickens, C.V.4    Mortier, N.A.5    Howard, T.A.6    Ware, R.E.7
  • 25
    • 77950622293 scopus 로고    scopus 로고
    • The effect of prolonged admin-istration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: Results of a 17-year, single-centertrial (LaSHS)
    • Voskaridou E, Christoulas D, Bilalis A, et al. The effect of prolonged admin-istration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-centertrial (LaSHS). Blood 2010; 115:2354-2363.
    • (2010) Blood , vol.115 , pp. 2354-2363
    • Voskaridou, E.1    Christoulas, D.2    Bilalis, A.3
  • 26
    • 0029025475 scopus 로고
    • Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
    • Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995; 332:131 7-1322.
    • (1995) N Engl J Med , vol.332 , pp. 1317-1322
    • Charache, S.1    Terrin, M.L.2    Moore, R.D.3
  • 28
    • 58249093004 scopus 로고    scopus 로고
    • Hydroxyurea for sickle cell disease: A systematic review for efficacy and toxicity in children
    • Strouse JJ, Lanzkron S, Beach MC, etal. Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. Pediatrics 2008; 122:1332-1342.
    • (2008) Pediatrics , vol.122 , pp. 1332-1342
    • Strouse, J.J.1    Lanzkron, S.2    Beach, M.C.3
  • 30
    • 74849091075 scopus 로고    scopus 로고
    • The pediatric hydroxyurea phase III clinical trial (BABY HUG): Challenges of study design
    • Thompson BW, Miller ST, Rogers ZR, etal. The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design. Pediatr Blood Cancer 2010; 54:250-255.
    • (2010) Pediatr Blood Cancer , vol.54 , pp. 250-255
    • Thompson, B.W.1    Miller, S.T.2    Rogers, Z.R.3
  • 31
    • 27944496081 scopus 로고    scopus 로고
    • Outcome of sickle cell anemia: A 4-decade observational study of 1056 patients
    • DOI 10.1097/01.md.0000189089.45003.52
    • Powars DR, Chan LS, Hiti A, etal. Outcome of sickle cell anemia: a4-decade observational study of 1056 patients. Medicine 2005; 84:363-376. (Pubitemid 41668935)
    • (2005) Medicine , vol.84 , Issue.6 , pp. 363-376
    • Powars, D.R.1    Chan, L.S.2    Hiti, A.3    Ramicone, E.4    Johnson, C.5
  • 32
    • 0028291736 scopus 로고
    • Mortality in sickle cell disease: Life expectancy and risk factors for early death
    • Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 1994; 330:1639-1644.
    • (1994) N Engl J Med , vol.330 , pp. 1639-1644
    • Platt, O.S.1    Brambilla, D.J.2    Rosse, W.F.3
  • 33
    • 37549007933 scopus 로고    scopus 로고
    • Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea
    • Hankins JS, Helton KJ, McCarville MB, et al. Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea. Pediatr Blood Cancer 2008; 50:293-297.
    • (2008) Pediatr Blood Cancer , vol.50 , pp. 293-297
    • Hankins, J.S.1    Helton, K.J.2    McCarville, M.B.3
  • 34
    • 34547961356 scopus 로고    scopus 로고
    • Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia
    • DOI 10.1182/blood-2006-11-057893
    • Zimmerman SA, Schultz WH, Burgett S, et al. Hydroxyurea therapy lowers transcranial Doppler flow velocities in children with sickle cell anemia. Blood 2007; 110:1043-1047. (Pubitemid 47267446)
    • (2007) Blood , vol.110 , Issue.3 , pp. 1043-1047
    • Zimmerman, S.A.1    Schultz, W.H.2    Burgett, S.3    Mortier, N.A.4    Ware, R.E.5
  • 36
    • 0021933164 scopus 로고
    • Developmental pattern of splenic dysfunction in sickle cell disorders
    • Pearson HA, Gallagher D, Chilcote R, et al. Developmental pattern of splenic dysfunction in sickle cell disorders. Pediatrics 1985; 76:392-397. (Pubitemid 15242503)
    • (1985) Pediatrics , vol.76 , Issue.3 , pp. 392-397
    • Pearson, H.A.1    Gallagher, D.2    Chilcote, R.3
  • 37
    • 50549162474 scopus 로고
    • A comparative study of renal concentrating ability in children with sickle cell anemia and in normal children
    • Whitten CF, Younes AA. A comparative study of renal concentrating ability in children with sickle cell anemia and in normal children. J Lab Clin Med 1960; 55:400-415.
    • (1960) J Lab Clin Med , vol.55 , pp. 400-415
    • Whitten, C.F.1    Younes, A.A.2
  • 38
    • 72049092388 scopus 로고    scopus 로고
    • Renal function in infants with sickle cell anemia: Baseline data from the BABY HUG trial
    • Ware RE, Rees RC, Sarnaik SA, et al. Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial. J Pediatr 2010; 156:66-70.
    • (2010) J Pediatr , vol.156 , pp. 66-70
    • Ware, R.E.1    Rees, R.C.2    Sarnaik, S.A.3
  • 39
    • 0025355908 scopus 로고
    • Renal abnormalities in sickle cell disease
    • DOI 10.1001/archinte.150.3.501
    • Allon M. Renal abnormalities in sickle cell disease. Arch Intern Med 1990; 150:501-504. (Pubitemid 20122000)
    • (1990) Archives of Internal Medicine , vol.150 , Issue.3 , pp. 501-504
    • Allon, M.1
  • 40
    • 0034105690 scopus 로고    scopus 로고
    • Renal abnormalities in sickle cell disease
    • Ataga KI, Orringer EP. Renal abnormalities in sickle cell disease. Am J Hematol 2000; 63:205-221.
    • (2000) Am J Hematol , vol.63 , pp. 205-221
    • Ataga, K.I.1    Orringer, E.P.2
  • 41
    • 77953057530 scopus 로고    scopus 로고
    • The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up
    • Steinberg MH, McCarthy WF, Castro O, et al. The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up. Am J Hematol 2010; 85:403-408.
    • (2010) Am J Hematol , vol.85 , pp. 403-408
    • Steinberg, M.H.1    McCarthy, W.F.2    Castro, O.3
  • 42
    • 80855145623 scopus 로고    scopus 로고
    • Hydroxyurea therapy reduces mortality among children with sickle cell disease ASH Annual Meeting Abstracts
    • Lobo C, Hankins JS, Moura P, Pinto JC. Hydroxyurea therapy reduces mortality among children with sickle cell disease. ASH Annual Meeting Abstracts. Blood 2010; 116:843a.
    • (2010) Blood , vol.116
    • Lobo, C.1    Hankins, J.S.2    Moura, P.3    Pinto, J.C.4
  • 44
    • 0013793439 scopus 로고
    • Induction of chromosome breaks in cultured normal human leukocytes by potassium arsenite, hydroxyurea and related compounds
    • Oppenheim JJ, Fishbein WN. Induction of chromosome breaks in cultured normal human leukocytes by potassium arsenite, hydroxyurea and related compounds. Cancer Res 1965; 25:980-985.
    • (1965) Cancer Res , vol.25 , pp. 980-985
    • Oppenheim, J.J.1    Fishbein, W.N.2
  • 45
    • 0022392453 scopus 로고
    • Microsome- and hepatocyte-mediated mutagenicity of hydroxyurea and related aliphatic hydroxamic acids in V79 Chinese hamster cells
    • Ziegler-Skylakakis K, Schwarz LR, Andrae U. Microsome-and hepatocyte-mediated mutagenicity of hydroxyurea and related aliphatic hydroxamic acids in V79 Chinese hamster cells. Mutat Res 1985; 152 (2-3):225-231. (Pubitemid 16198555)
    • (1985) Mutation Research , vol.152 , Issue.2-3 , pp. 225-231
    • Ziegler-Skylakakis, K.1    Schwarz, L.R.2    Andrae, U.3
  • 46
    • 0007088448 scopus 로고
    • Preliminary survey of hydroxyurea (Nsc-32065) as a teratogen
    • Murphy ML, Chaube S. Preliminary survey of hydroxyurea (Nsc-32065) as a teratogen. Cancer Chemother Rep 1964; 40:1-7.
    • (1964) Cancer Chemother Rep , vol.40 , pp. 1-7
    • Murphy, M.L.1    Chaube, S.2
  • 47
    • 0035206628 scopus 로고    scopus 로고
    • Hydroxyurea induces site-specific DNA damage via formation of hydrogen peroxide and nitric oxide
    • Sakano K, Oikawa S, Hasegawa K, Kawanishi S. Hydroxyurea induces site-specific DNA damage via formation of hydrogen peroxide and nitric oxide. Jpn J Cancer Res 2001; 92:1166-1174. (Pubitemid 33133485)
    • (2001) Japanese Journal of Cancer Research , vol.92 , Issue.11 , pp. 1166-1174
    • Sakano, K.1    Oikawa, S.2    Hasegawa, K.3    Kawanishi, S.4
  • 48
    • 0035383785 scopus 로고    scopus 로고
    • Five years of experience with hydroxyurea in children and young adults with sickle cell disease
    • Ferster A, Tahriri P, Vermylen C, et al. Five years of experience with hydroxyurea in children and young adults with sickle cell disease. Blood 2001; 97:3628-3632.
    • (2001) Blood , vol.97 , pp. 3628-3632
    • Ferster, A.1    Tahriri, P.2    Vermylen, C.3
  • 49
    • 77954934323 scopus 로고    scopus 로고
    • Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemia
    • Flanagan JM, Howard TA, Mortier N, et al. Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemia. Mutat Res 2010; 698:38-42.
    • (2010) Mutat Res , vol.698 , pp. 38-42
    • Flanagan, J.M.1    Howard, T.A.2    Mortier, N.3
  • 50
    • 79955001744 scopus 로고    scopus 로고
    • Chromosome damage and repair in children with sickle cell anemia and long-term hydroxyurea exposure
    • ASPHO Annual Meeting Abstract press
    • McGann PT, Howard TA, Flanagan JM, et al. Chromosome damage and repair in children with sickle cell anemia and long-term hydroxyurea exposure. ASPHO Annual Meeting Abstract. Pediatr Blood Cancer (in press).
    • Pediatr Blood Cancer
    • McGann, P.T.1    Howard, T.A.2    Flanagan, J.M.3
  • 51
    • 79955005753 scopus 로고    scopus 로고
    • From infancy to adolescence: Over a decade of continuous hydroxyurea therapy in sickle cell anemia
    • ASPHO Annual Meeting Abstract
    • Hankins JS, Aygun B, Wang W, et al. From infancy to adolescence: over a decade of continuous hydroxyurea therapy in sickle cell anemia. ASPHO Annual Meeting Abstract. Pediatr Blood Cancer 2010; 54:790.
    • (2010) Pediatr Blood Cancer , vol.54 , pp. 790
    • Hankins, J.S.1    Aygun, B.2    Wang, W.3
  • 52
    • 77953952024 scopus 로고    scopus 로고
    • The inherited diseases of hemoglobin are an emerging global health burden
    • Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood 2010; 115:4331-4336.
    • (2010) Blood , vol.115 , pp. 4331-4336
    • Weatherall, D.J.1
  • 53
    • 77951712618 scopus 로고    scopus 로고
    • Improved survival of children and adolescents with sickle cell disease
    • Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood 2010; 115:3447-3452.
    • (2010) Blood , vol.115 , pp. 3447-3452
    • Quinn, C.T.1    Rogers, Z.R.2    McCavit, T.L.3    Buchanan, G.R.4
  • 54
    • 12844276479 scopus 로고    scopus 로고
    • A case for developing North-South partnerships for research in sickle cell disease
    • DOI 10.1182/blood-2004-06-2404
    • Weatherall D, Hofman K, Rodgers G, et al. A case for developing North-South partnerships for research in sickle cell disease. Blood 2005; 105:921-923. (Pubitemid 40170855)
    • (2005) Blood , vol.105 , Issue.3 , pp. 921-923
    • Weatherall, D.1    Hofman, K.2    Rodgers, G.3    Ruffin, J.4    Hrynkow, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.